Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study.
biomarker
bladder cancer
digital pathology
immunoscore
prognosis
progression
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
06
2022
accepted:
05
09
2022
entrez:
10
10
2022
pubmed:
11
10
2022
medline:
11
10
2022
Statut:
epublish
Résumé
Tumour-infiltrating lymphocytes (TIL), known to be of prognostic value in various solid tumours, have been in the focus of research in the last years. TIL are often quantified
Identifiants
pubmed: 36212478
doi: 10.3389/fonc.2022.964672
pmc: PMC9539272
doi:
Types de publication
Journal Article
Langues
eng
Pagination
964672Informations de copyright
Copyright © 2022 Bieri, Enderlin, Buser, Wettstein, Eberli, Moch, Hermanns and Poyet.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflict of interest.
Références
Eur Urol. 2019 Nov;76(5):639-657
pubmed: 31443960
Oncoimmunology. 2020 Oct 13;9(1):1832324
pubmed: 33194318
Lancet. 2018 May 26;391(10135):2128-2139
pubmed: 29754777
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3967-72
pubmed: 17360461
Eur J Cancer. 2021 Mar;145:221-229
pubmed: 33516050
Ann Oncol. 2020 Oct;31(10):1291-1305
pubmed: 32702383
J Urol. 1993 Jul;150(1):60-4
pubmed: 8510276
Oncotarget. 2016 Feb 9;7(6):6424-35
pubmed: 26824503
Clin Cancer Res. 2020 Jan 15;26(2):332-339
pubmed: 31413009
Cell Rep. 2016 Oct 18;17(4):1206
pubmed: 27760322
Arch Esp Urol. 2021 Dec;73(10):929-933
pubmed: 33269711
Semin Cancer Biol. 2022 Sep;84:89-102
pubmed: 33631295
Oncol Lett. 2015 Nov;10(5):2753-2760
pubmed: 26722237
Urology. 2005 Dec;66(6 Suppl 1):4-34
pubmed: 16399414
Nat Med. 1998 Jul;4(7):844-7
pubmed: 9662379
Urol Clin North Am. 2020 Nov;47(4S):e17-e54
pubmed: 33446323
Ann Surg Oncol. 2019 Nov;26(12):4148-4156
pubmed: 31376036
Int J Biol Markers. 2020 Sep;35(3):3-13
pubmed: 32538254
J Clin Oncol. 2021 Jan 20;39(3):202-214
pubmed: 33332191
J Korean Med Sci. 1993 Apr;8(2):135-44
pubmed: 8397930
J Transl Med. 2012 Oct 03;10:205
pubmed: 23034130
Oncoimmunology. 2021 Jan 15;10(1):1868130
pubmed: 33537173
Cochrane Database Syst Rev. 2017 Mar 08;3:CD012112
pubmed: 28268259
Croat Med J. 2012 Dec;53(6):598-604
pubmed: 23275325
Diagnostics (Basel). 2022 Jun 01;12(6):
pubmed: 35741170
Eur Urol. 1992;21 Suppl 2:17-21
pubmed: 1396942
Eur Urol. 2006 Mar;49(3):466-5; discussion 475-7
pubmed: 16442208
Dis Markers. 2015;2015:785461
pubmed: 26543299
Am J Transl Res. 2020 Oct 15;12(10):6524-6536
pubmed: 33194049
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
J Urol. 2007 Jan;177(1):353-8
pubmed: 17162090
BMC Clin Pathol. 2014 Mar 13;14(1):10
pubmed: 24624923
J Immunol. 2017 Feb 1;198(3):981-985
pubmed: 28115586
Cancers (Basel). 2021 Jan 28;13(3):
pubmed: 33525361
Oncoimmunology. 2021 Feb 17;10(1):1888488
pubmed: 33659099
Int J Mol Sci. 2020 Nov 09;21(21):
pubmed: 33182484
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18627-18637
pubmed: 32680964
Eur Urol Focus. 2022 Mar;8(2):438-446
pubmed: 33771477
BJU Int. 2011 Nov;108(10):1672-8
pubmed: 21244603
J Endourol. 2007 Dec;21(12):1533-41
pubmed: 18186695
Br J Cancer. 2013 Sep 17;109(6):1460-6
pubmed: 23982601
World J Urol. 2016 Feb;34(2):181-7
pubmed: 26055646
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
JAMA. 2020 Nov 17;324(19):1980-1991
pubmed: 33201207
Head Neck. 2019 Aug;41(8):2789-2800
pubmed: 30821023